Hershey Financial Advisers’s ARK Genomic Revolution ETF ARKG Stock Holding History

Hershey Financial Advisers’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	$1.13K	Buy	+48	New	+$1.21K	﹤0.01%	146

Other funds holding ARKG

MMEA

Main Management ETF Advisors San Francisco, California $2.68B AUM 24.27% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Hershey Financial Advisers's ARKG Position: Q2 2024 in Review

Hershey Financial Advisers opened a new position in ARK Genomic Revolution ETF (ARKG) in Q2 2024: 48 shares worth $1.13K. The stake represents ﹤0.01% of the portfolio and ranks #146 among its holdings.

261 funds tracked by Wall St. Rank hold ARKG as of Q2 2024.

Hershey Financial Advisers held 48 shares of ARK Genomic Revolution ETF worth $1.13K as of Q2 2024.
ARK Genomic Revolution ETF was a new Hershey Financial Advisers position in Q2 2024.
ARK Genomic Revolution ETF made up ﹤0.01% of Hershey Financial Advisers's portfolio in Q2 2024, its #146 holding.
261 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2024.

Based on Hershey Financial Advisers's 13F filing for Q2 2024, filed 19 Aug 2024.